| Dr David Scott Rubin, MD | |
|
13847 Horace Harding Expy, Flushing, NY 11367-1131 | |
| (718) 461-5813 | |
| (718) 321-8095 |
| Full Name | Dr David Scott Rubin |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 41 Years |
| Location | 13847 Horace Harding Expy, Flushing, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003857616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 158805 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The World Health Clinicians Incorporated | 0941470843 | 3 |
News Archive
Serum asymmetric dimethylarginine may be an effective non-invasive screening biomarker for systemic sclerosis-related pulmonary arterial hypertension, study findings indicate.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending June 30, 2014. The Company highlighted important corporate, commercial, regulatory and clinical development updates from the quarter.
Stem cells culled from bone marrow may prove beneficial in stroke recovery, scientists at UC Irvine's Sue & Bill Gross Stem Cell Research Center have learned.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.
› Verified 8 days ago
| Entity Name | The World Health Clinicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861799827 PECOS PAC ID: 0941470843 Enrollment ID: O20110901000499 |
News Archive
Serum asymmetric dimethylarginine may be an effective non-invasive screening biomarker for systemic sclerosis-related pulmonary arterial hypertension, study findings indicate.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending June 30, 2014. The Company highlighted important corporate, commercial, regulatory and clinical development updates from the quarter.
Stem cells culled from bone marrow may prove beneficial in stroke recovery, scientists at UC Irvine's Sue & Bill Gross Stem Cell Research Center have learned.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Scott Rubin, MD 13847 Horace Harding Expy, Flushing, NY 11367-1131 Ph: (718) 461-5813 | Dr David Scott Rubin, MD 13847 Horace Harding Expy, Flushing, NY 11367-1131 Ph: (718) 461-5813 |
News Archive
Serum asymmetric dimethylarginine may be an effective non-invasive screening biomarker for systemic sclerosis-related pulmonary arterial hypertension, study findings indicate.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending June 30, 2014. The Company highlighted important corporate, commercial, regulatory and clinical development updates from the quarter.
Stem cells culled from bone marrow may prove beneficial in stroke recovery, scientists at UC Irvine's Sue & Bill Gross Stem Cell Research Center have learned.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.
› Verified 8 days ago
Ms. Min Cai, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4105 College Point Blvd, Suite 1c, Flushing, NY 11355 Phone: 718-321-0558 Fax: 718-321-1672 | |
Xueshu Zhang, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 133-47 Sanford Avenue, Suite 1f, Flushing, NY 11355 Phone: 718-359-5780 Fax: 718-359-5821 | |
Haoxu Ouyang, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13227 41st Rd # 2c, Flushing, NY 11355 Phone: 718-269-5055 | |
Mu-i Karen Kuo, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 13259 41st Rd, Suite Cb, Flushing, NY 11355 Phone: 718-939-6234 Fax: 718-939-6235 | |
Evan Choi, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000 | |
Dr. Mustafa Salehmohamed, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Wa-100, Flushing, NY 11355 Phone: 718-670-1405 |